Citation Impact
Citing Papers
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Finishing the euchromatic sequence of the human genome
2004 StandoutNature
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
1987 StandoutNature
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy
1999
Coexpression of Wild-Type Tyrosinase Enhances Maturation of Temperature-Sensitive Tyrosinase Mutants
2002
Induction of cellular contractions in the human melanoma cell line SK-mel 28 after muscarinic cholinergic stimulation
2000
Development and differentiation of glial precursor cells in the rat cerebellum
1993
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Proper Folding and Endoplasmic Reticulum to Golgi Transport of Tyrosinase Are Induced by Its Substrates, DOPA and Tyrosine
2001
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
2002
Antibody therapy of cancer
2012 Standout
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
2007
Cancer-associated carbohydrates identified by monoclonal antibodies
1990
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides
1997
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection
2003
Serological identification of breast cancer-related antigens from aSaccharomyces cerevisiae surface display library
2005
A reappraisal of ganglioside GD3 expression in the CNS
1996
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Carbonic anhydrase in distinct precursors of astrocytes and oligodendrocytes in the forebrains of neonatal and young rats
1992
Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro
1992
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Amoeboid microglia expressing GD3 ganglioside are concentrated in regions of oligodendrogenesis during development of the rat corpus callosum
1995
The Menkes copper transporter is required for the activation of tyrosinase
2000
Cancer vaccines and carbohydrate epitopes
2011
Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway
2002
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
The biology of the 17–1A antigen (Ep-CAM)
1999
Expression of GD3 ganglioside by developing rat cerebellar purkinje cells in situ
1988
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Strongly GD3+ cells in the developing and adult rat cerebellum belong to the microglial lineage rather than to the oligodendrocyte lineage
1995
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
1994
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis
2001
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.
1988 StandoutNobel
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Genes of the Major Histocompatibility Complex in Mouse and Man
1983 Science
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
2003
EpCAM and the biology of hepatic stem/progenitor cells
2014
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 StandoutScience
The Ly phenotype of suppressor T cells arising in mice subjected to a graft-versus-host reaction.
1977
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
1997
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.
1983
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
1981
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
1989
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Structural and kinetic basis for heightened immunogenicity of T cell vaccines
2005
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
Astroglial control of oligodendrocyte survival mediated by PDGF and Leukemia Inhibitory Factor-like protein
1995
Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
1997
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Viewing Siglecs through the lens of tumor immunology
2017
Immune mechanisms in leukemia role of the Ia antigens.
1977
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Drug Discovery: A Historical Perspective
2000 StandoutScience
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Killer cells reactive to altered-self antigens can also be alloreactive.
1977
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
1991 StandoutScience
Unusual organization and diversity of T-cell receptor a-chain genes
1985 StandoutNatureNobel
Molecular probes for the development and plasticity of neural crest derivatives
1985 StandoutNobel
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
2006
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
1990
Functional and inducible expression of a transfected murine class II major histocompatibility complex gene.
1984 StandoutNobel
Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism
2000
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera
1979
Blocking effect of lyt-2 antibodies on T cell functions.
1980
Sequences and Factors: A Guide to MHC Class-II Transcription
1992
Multimodality Agents for Tumor Imaging (PET, Fluorescence) and Photodynamic Therapy. A Possible “See and Treat” Approach
2005
Maintenance of in Vivo Tolerance by Persistence of Antigen
1992 StandoutScienceNobel
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.
1985
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Novel function for beta 1 integrins in keratinocyte cell-cell interactions.
1990
Wound repair, keratinocyte activation and integrin modulation
1992
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
In vivo induction of H‐2K/D antigens by recombinant interferon‐γ
1986
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity
1994
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.
1987
Replacing the complementarity-determining regions in a human antibody with those from a mouse
1986 StandoutNatureNobel
A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus
1987 StandoutNobel
CD1: Antigen Presentation and T Cell Function
2004
Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma
2005
Biological therapy of cancer
1986
Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.
1985
T Cells, T Cell Recognition Structures, and the Major Histocompatibility Complex
1978 StandoutNobel
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Human monoclonal antibodies — production and potential
1984
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
2003
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.
1978 StandoutNobel
Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.
1984 StandoutNobel
A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells
1986
Identification of early neuronal subpopulations in avian neural crest cell cultures
1985
Works of L J Old being referenced
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
1993
Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments
2004
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.
1993
Immunogenetics of Human Cell Surface Differentiation
1989
Characterization of Posttranslational Modifications of Human A33 Antigen, a Novel Palmitoylated Surface Glycoprotein of Human Gastrointestinal Epithelium
1997
Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells
1987
Changes in Cell Surface Glycoprotein Expression During Differentiation of Human Keratinocytes
1987
Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients.
1989
AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.
1979
Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
1987
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
1983
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
1982
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
1995
Ly phenotype of cytotoxic T cells for syngeneic tumor.
1976
Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
2001
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
1985
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.
1996
Structural comparisons of TL antigens derived from normal and leukemia cells of Tl+ and TL- strains and relationship to genetically linked H-2 major histocompatibility complex products.
1981
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
1984
Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
1990
Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer.
1988
Signaling and signaling dysfunction through the interferon gamma receptor.
1998